Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
Published 1 month, 1 week ago
Description
In today's Pharmaceutical Executive Daily, activist investor Shah Capital escalates its campaign against Novavax's board ahead of the company's annual meeting, a Louisiana federal judge declines to block mail-order access to mifepristone while leaving open the possibility of a future ruling against it, and a Q&A examines how the pharmaceutical industry is navigating the compounding pressures of the Iran war and tariff uncertainty on global supply chains.